269 related articles for article (PubMed ID: 25830765)
1. Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Roksnoer LC; van Veghel R; de Vries R; Garrelds IM; Bhaggoe UM; Friesema EC; Leijten FP; Poglitsch M; Domenig O; Clahsen-van Groningen MC; Hoorn EJ; Jan Danser AH; Batenburg WW
Kidney Int; 2015 Jul; 88(1):109-20. PubMed ID: 25830765
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
Prasad T; Roksnoer LC; Zhu P; Verma A; Li Y; Batenburg WW; de Vries R; Danser AH; Li Q
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6722-6730. PubMed ID: 27951594
[TBL] [Abstract][Full Text] [Related]
3. Neprilysin inhibition and endothelin-1 elevation: Focus on the kidney.
Roksnoer LCW; Uijl E; de Vries R; Garrelds IM; Jan Danser AH
Eur J Pharmacol; 2018 Apr; 824():128-132. PubMed ID: 29432709
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure-independent renoprotection in diabetic rats treated with AT1 receptor-neprilysin inhibition compared with AT1 receptor blockade alone.
Roksnoer LC; van Veghel R; Clahsen-van Groningen MC; de Vries R; Garrelds IM; Bhaggoe UM; van Gool JM; Friesema EC; Leijten FP; Hoorn EJ; Danser AH; Batenburg WW
Clin Sci (Lond); 2016 Jul; 130(14):1209-20. PubMed ID: 27129187
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
Ferro CJ; Spratt JC; Haynes WG; Webb DJ
Circulation; 1998 Jun; 97(23):2323-30. PubMed ID: 9639376
[TBL] [Abstract][Full Text] [Related]
6. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
7. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
Azizi M; Bissery A; Peyrard S; Guyene TT; Ozoux ML; Floch A; Ménard J
Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
[TBL] [Abstract][Full Text] [Related]
9. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
[TBL] [Abstract][Full Text] [Related]
10. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
11. Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.
de Beer VJ; Sorop O; Pijnappels DA; Dekkers DH; Boomsma F; Lamers JM; Duncker DJ; Merkus D
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2069-77. PubMed ID: 18310517
[TBL] [Abstract][Full Text] [Related]
12. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
[TBL] [Abstract][Full Text] [Related]
13. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.
Seccia TM; Caroccia B; Gioco F; Piazza M; Buccella V; Guidolin D; Guerzoni E; Montini B; Petrelli L; Pagnin E; Ravarotto V; Belloni AS; Calò LA; Rossi GP
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27444511
[TBL] [Abstract][Full Text] [Related]
15. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
[TBL] [Abstract][Full Text] [Related]
16. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor-neprilysin inhibitior (thiorphan/irbesartan) decreased ischemia-reperfusion induced ventricular arrhythmias in rat; in vivo study.
Abdulsalam TM; Hasanin AH; Mohamed RH; El Sayed Badawy A
Eur J Pharmacol; 2020 Sep; 882():173295. PubMed ID: 32593664
[TBL] [Abstract][Full Text] [Related]
18. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.
Seccia TM; Belloni AS; Kreutz R; Paul M; Nussdorfer GG; Pessina AC; Rossi GP
J Am Coll Cardiol; 2003 Feb; 41(4):666-73. PubMed ID: 12598081
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
Matsumoto T; Ozawa Y; Taguchi K; Kobayashi T; Kamata K
Peptides; 2010 Feb; 31(2):346-53. PubMed ID: 19962413
[TBL] [Abstract][Full Text] [Related]
20. Effect of neutral endopeptidase inhibition on vascular response induced by exogenous angiotensin I in the isolated rat lung.
Bartuś JB; Chłopicki S
Pol J Pharmacol; 2003; 55(6):1071-8. PubMed ID: 14730103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
